checkAd

     225  0 Kommentare Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application - Seite 3


    804-513-4758                                                                  
    dinnes@nwbio.com                                                                                            

    Les Goldman
    240-234-0059
    lgoldman@nwbio.com

    Logo - https://mma.prnewswire.com/media/325355/northwest_biotherapeutics__inc ...  

    Lesen Sie auch

    Cision View original content:https://www.prnewswire.co.uk/news-releases/northwest-biotherapeutics-provides-update-on-near-term-plans-for-submission-of-marketing-authorization-application-301956190.html


    The Northwest Biotherapeutics Stock at the time of publication of the news with a raise of 0,00 % to 0,75EUR on Tradegate stock exchange (12. Oktober 2023, 22:26 Uhr).
    Seite 3 von 3



    Diskutieren Sie über die enthaltenen Werte



    PR Newswire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von PR Newswire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application - Seite 3 BETHESDA, Md., Oct. 13, 2023 /PRNewswire/ - Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, provided an update today about its progress toward …